Literature DB >> 19121253

Back to Wilson and Jungner: 10 good reasons to screen for type 2 diabetes mellitus.

Ann M Sheehy1, Douglas B Coursin, Robert A Gabbay.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19121253      PMCID: PMC2664569          DOI: 10.1016/S0025-6196(11)60806-9

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  24 in total

1.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

2.  Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies.

Authors:  Ping Zhang; Michael M Engelgau; Rodolfo Valdez; Stephanie M Benjamin; Betsy Cadwell; K M Venkat Narayan
Journal:  Diabetes Care       Date:  2003-09       Impact factor: 19.112

3.  UKPDS and the legacy effect.

Authors:  John Chalmers; Mark E Cooper
Journal:  N Engl J Med       Date:  2008-10-09       Impact factor: 91.245

4.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

5.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

6.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

Review 7.  Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:  Susan L Norris; Devan Kansagara; Christina Bougatsos; Rongwei Fu
Journal:  Ann Intern Med       Date:  2008-06-03       Impact factor: 25.391

Review 8.  A new look at screening and diagnosing diabetes mellitus.

Authors:  Christopher D Saudek; William H Herman; David B Sacks; Richard M Bergenstal; David Edelman; Mayer B Davidson
Journal:  J Clin Endocrinol Metab       Date:  2008-05-06       Impact factor: 5.958

9.  Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes.

Authors:  Frank B Hu; Meir J Stampfer; Steven M Haffner; Caren G Solomon; Walter C Willett; JoAnn E Manson
Journal:  Diabetes Care       Date:  2002-07       Impact factor: 19.112

10.  Translating the A1C assay into estimated average glucose values.

Authors:  David M Nathan; Judith Kuenen; Rikke Borg; Hui Zheng; David Schoenfeld; Robert J Heine
Journal:  Diabetes Care       Date:  2008-06-07       Impact factor: 19.112

View more
  13 in total

1.  Revisiting screening for type 2 diabetes mellitus: to screen or not to screen, that is the question.

Authors:  Saleh A Aldasouqi; Ved V Gossain
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

Review 2.  Reasons to exercise caution when considering a screening program for type 2 diabetes mellitus.

Authors:  Frank H Lawler
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

3.  The History of the Data Systems AutoChemist® (ACH) and AutoChemist- PRISMA (PRISMA®): from 1964 to 1986.

Authors:  L Ohlsén; I Jungner; H E Peterson
Journal:  Yearb Med Inform       Date:  2014-05-22

Review 4.  Perioperative and critical illness dysglycemia--controlling the iceberg.

Authors:  Mark T Keegan; Michael E Goldberg; Marc C Torjman; Douglas B Coursin
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 5.  An overview of preoperative glucose evaluation, management, and perioperative impact.

Authors:  Ann M Sheehy; Robert A Gabbay
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

6.  Increased cardiovascular disease, resource use, and costs before the clinical diagnosis of diabetes in veterans in the southeastern U.S.

Authors:  Darin E Olson; Ming Zhu; Qi Long; Diana Barb; Jeehea S Haw; Mary K Rhee; Arun V Mohan; Phyllis I Watson-Williams; Sandra L Jackson; Anne M Tomolo; Peter W F Wilson; K M Venkat Narayan; Joseph Lipscomb; Lawrence S Phillips
Journal:  J Gen Intern Med       Date:  2015-01-22       Impact factor: 5.128

7.  Development and validation of a patient self-assessment score for diabetes risk.

Authors:  Heejung Bang; Alison M Edwards; Andrew S Bomback; Christie M Ballantyne; David Brillon; Mark A Callahan; Steven M Teutsch; Alvin I Mushlin; Lisa M Kern
Journal:  Ann Intern Med       Date:  2009-12-01       Impact factor: 25.391

8.  Electronic health record phenotyping improves detection and screening of type 2 diabetes in the general United States population: A cross-sectional, unselected, retrospective study.

Authors:  Ariana E Anderson; Wesley T Kerr; April Thames; Tong Li; Jiayang Xiao; Mark S Cohen
Journal:  J Biomed Inform       Date:  2015-12-17       Impact factor: 6.317

9.  Analysis of guidelines for screening diabetes mellitus in an ambulatory population.

Authors:  Ann M Sheehy; Grace E Flood; Wen-Jan Tuan; Jinn-ing Liou; Douglas B Coursin; Maureen A Smith
Journal:  Mayo Clin Proc       Date:  2010-01       Impact factor: 7.616

10.  Low lung function and risk of type 2 diabetes in Japanese men: the Toranomon Hospital Health Management Center Study 9 (TOPICS 9).

Authors:  Yoriko Heianza; Yasuji Arase; Hiroshi Tsuji; Kazumi Saito; Kazuhisa Amakawa; Shiun Dong Hsieh; Satoru Kodama; Hitoshi Shimano; Nobuhiro Yamada; Shigeko Hara; Hirohito Sone
Journal:  Mayo Clin Proc       Date:  2012-09       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.